+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of transdermal and subcutaneous administration of estradiol in the treatment of climacteric symptoms



Comparison of transdermal and subcutaneous administration of estradiol in the treatment of climacteric symptoms



Nederlands Tijdschrift Voor Geneeskunde 131(50): 2301-2304




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039637307

Download citation: RISBibTeXText

PMID: 3696269


Related references

Comparison of the effects of oral and transdermal estradiol administration on estrogen metabolism protein synthesis gonadotropin release bone turnover and climacteric symptoms in postmenopausal women. Clinical Endocrinology 30(3): 241-250, 1989

Transdermal estradiol substitution in the postmenopause, individual dosage adjustment and effectiveness in the treatment of climacteric symptoms. Schweizerische Rundschau für Medizin Praxis 76(14): 358-361, 1987

Randomised Comparison of Acceptability and Efficacy of Intranasal 17β-estradiol and Transdermal Estradiol for the Treatment of Menopausal Symptoms. Menopause 6(4): 362-363, 1999

Transdermal 17 beta estradiol patches for the control of climacteric symptoms. International Journal of Gynecology & Obstetrics (ABSTR Suppl.): 385, 1991

Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies. Arzneimittel-Forschung 49(11): 933-943, 1999

Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climacteric symptoms in postmenopausal women. Clinical Endocrinology 30(3): 241-249, 1989

An open, randomized assessment of the efficacy and safety of two transdermal estradiol patches for relief of climacteric symptoms. Maturitas 27(Suppl. ): 209, 1997

Efficacy and tolerability of transdermal 17 beta-estradiol in patients with climacteric symptoms: Dose titration according to individual choice. Current Therapeutic Research 57(7): 506-515, 1996

Clinical experience with transdermal estradiol in the treatment of the climacteric. Minerva Endocrinologica 14(1): 45-48, 1989

Splenopeptides for climacteric complaints. Comparison of ovarian stimulation with transdermal estradiol substitution. Arzneimittel-Forschung 45(3): 315-322, 1995

Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study. Arzneimittel-Forschung 50(3): 293-300, 2000

Electroosmotic transdermal administration of polypeptides comparison of luteinizing hormone response to transdermal and subcutaneous leuprolide. Clinical Pharmacology & Therapeutics 45(2): 129, 1989

Transdermal administration of polypeptides by electroosmosis a comparison of luteinizing hormone response to subcutaneous and transdermal leuprolide. Journal of Controlled Release 13(2-3): 325, 1990

Effect of transdermal administration of 17-beta estradiol on the release of growth hormone by growth hormone liberating hormone (GH-RH-1-29) in climacteric women before and after treatment. Ginecologia Y Obstetricia de Mexico 69: 379-385, 2001

Comparative efficacy and safety of estradiol transdermal preparations for the treatment of vasomotor symptoms in postmenopausal women: an indirect comparison meta-analysis. Menopause 23(3): 294-303, 2016